Comparison of an intravenous pulse of methylprednisolone versus oral corticosteroid in severe acute rheumatic carditis: A randomized clinical trial

Cardiology in the Young

Volumn 12, Issue 2, 2002, Pages 119-124

  Nassri Câmara, Edmundo José ^a,b   Vieira Braga, Júlio César ^a   Alves Silva, Luiz Sérgio ^a   Câmara, Gabriel Ferreira ^a   Da Silva Lopes, Antonio Alberto ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b NONE   (Brazil)

Author keywords

Carditis; Corticosteroids; Pulse therapy; Rheumatic fever

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISONE;

ACUTE DISEASE; ADOLESCENT; ARTICLE; BRAZIL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; HEART EJECTION FRACTION; HEART RATE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC DISEASE; SEDIMENTATION RATE; TREATMENT FAILURE; COMPARATIVE STUDY; DRUG PULSE THERAPY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; MYOCARDITIS; NONPARAMETRIC TEST; ORAL DRUG ADMINISTRATION; PROBABILITY; REFERENCE VALUE; RHEUMATIC HEART DISEASE; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADOLESCENT; CHILD; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MYOCARDITIS; PREDNISONE; PROBABILITY; PULSE THERAPY, DRUG; REFERENCE VALUES; RHEUMATIC HEART DISEASE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 0036513947     PISSN: 10479511     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1047951102000264     Document Type: Article

References (34)

1. Achutti A, Achutti VR. Epidemiology of rheumatic fever in the developing world. Cardiol Young 1992; 2: 206-215.
2. Kaplan EL. Rheumatic fever at the end of the twentieth century: why is there a problem? Cardiol Young 1992; 2: 204-205.
3. Meira ZMA, Castilho SRT, Barros MVL, et al. Prevalência da febre reumática em crianças de uma escola pública de Belo Horizonte. Arq Bras Cardiol 1995; 65: 331-334.
4. Stollerman GH. Rheumatic fever. Lancet 1995; 349: 935-942.
5. Snitcowsky R. Profilaxia da febre reumática. Rev Soc Cardiol ESP 1993; 6: 17-20.
6. Bhattacharya SK, Jha BN, Somani PN. Carditis in acute rheumatic fever in Varanasi, India. Trop Geogr Med 1974; 26: 271-277.
7. Lue HC, Chen CL, Wei H, et al. The natural history of rheumatic fever and rheumatic heart disease in the Orient. Jpn Heart J 1979; 20: 237-252.
8. Majeed HA, Yousof AM, Shaltout A, Khuffash FA. Acute rheumatic fever below the age of five years: a prospective study of the clinical profile. Ann Trop Paediatr 1984; 4: 37-40.
9. Tolaymat A, Goudarzi T, Soler GP, Miller RH, Ayoub EM. Acute rheumatic fever in north Florida. South Med J 1984; 77: 819-823.
10. Silva CM, Hilario MOE, Carvalho AC. Tratamento da cardite reumática. Rev Soc Cardiol ESP 1993; 3: 21-25.
11. Carapetis JR, Currie BJ. Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in aboriginal people. Aust NZJ Public Health 1999; 23: 159-163.
12. Bitar FF, Hayek P, Obeid M, Gharzeddine W, Mikati M, Dbaibo GS. Rheumatic fever. Pediatr Cardiol 2000; 21: 119-122.
13. Stolzer BL, Houser HB, Clark EJ. Therapeutic agents in rheumatic carditis. Arch Intern Med 1955; 95: 677-688.
14. Czoniczer G, Amezcua F, Pelargonia S, Massell BF. Therapy of severe rheumatic carditis. Circulation 1964; 29: 813-819.
15. Albert DA, Harel L, Karrison T. The treatment of rheumatic carditis: a review and meta-analysis. Medicine 1995; 74: 1-14.
16. Cathcart ES, Idelson BA, Scheinberg MA, Couser WG. Beneficial effects of methylprednisolone pulse therapy in diffuse proliferative lupus nephritis. Lancet 1976; 1: 163-166.
17. Barron KS, Person DA, Brewer EJ Jr, Beale MG, Robson AM. Pulse methylprednisolone therapy in diffuse proliferative lupus nephritis. J Pediatr 1982; 101: 137-141.
18. Baqi N, Moazami S, Singh A, Ahmad H, Balachandra, Tejani A. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 1996; 7: 924-929.
19. Couto AA, Martins JCS, Mansur EM. Metilprednisolona em altas doses (pulsoterapia): possível solução terapeutica para afebre reumática ativa com cardite grave. Arq Bras Cardiol 1984; 43: 97-101.
20. Couto AA, Oliveira GMM, Campos AL, et al. Duração da atividade reumática em pacientes tratados com corticoide oral vs. pulsoterapia. Arq Bras Cardiol 1987; 48: 371-373.
21. Herdy GVH, Couto AA, Lipka P, Al Odeh C, Drummond S. Pulsoterapia (altas doses de metil-prednisolona venosa) em crianças com cardite reumática. J Ped 1988; 64: 317-323.
22. Herdy GVH, Couto AA, Fernandes JCM, Olivaes MCD, Berger R, Elias VE. Pulsoterapia (altas doses de metil-prednisolona venosa) em crianças com cardite reumática. Estudo prospectivo de 40 episódios. Arq Bras Cardiol 1993; 60: 377-381.
23. Special writing group of the committee on rheumatic fever, endocarditis, and Kawasaki disease of the council on cardiovascular disease in the young, American Heart Association. Guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992. Circulation 1993; 87: 302-307.
24. Décourt LV. Como eu trato: doenća reumática ativa. Rev Soc Cardiol ESP 1993; 4: 20-28.
25. Feitosa GS, Oliveira R, Neri AC, Leite ML, Brito JC. Pulsoterapia em cardite reumática resistente ao corticoide oral. Arq Bras Cardiol 1988; LI (Suppl 74): 51.
26. Rheumatic Fever Working Party (RFWP) of the MRC, Great Britain, and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children: a cooperative clinical trial of ACTH, cortisone and aspirin. Circulation 1955; 2: 343-371.
27. Combined Rheumatic Fever Study Group (RFSG). A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic carditis. N Engl J Med 1960; 262: 895-902.
28. United Kingdom and United States Joint Report. The evolution of rheumatic heart disease in children. Five-year report of a cooperative clinical trial of ACTH, cortisone and aspirin. Circulation 1960; 22: 503-515.
29. Combined Rheumatic Fever Study Group (RFSG). A comparison of short-term intensive prednisone and acetyl salicylic acid therapy in the treatment of acute rheumatic fever. N Engl J Med 1965; 272: 63-70.
30. United Kingdom and United States Joint report. The natural history of rheumatic fever and rheumatic heart disease. Ten-year report of cooperative clinical trial of ACTH, cortisone and aspirin. Circulation 1965; 32: 457-476.
31. Butler WT, Rossen RD. Effects of corticosteroids on immunity in man. J Clin Invest 1973; 52: 2629-2637.
32. Lang B, Dooley J. Failure of pulse intravenous methylprednisolone treatment in juvenile dermatomyositis. J Pediatrics 1996; 128: 429-432.
33. Gourley MF, Austin HA III, Scott D, et al. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med 1996; 125: 549-557.
34. Klein-Gitelman MS, Pachman LM. Intravenous corticosteroids: adverse reactions are more variable than expected in children. J Rheumatol 1998; 25: 1995-2002.